This study combining data from several large epidemiological studies provides no strong support for a causal role of circulating FABP-4 in overall CRC risk, although the cis-MR provides some evidence for a positive association in women, which may deserve to be further investigated. Here, FABP4 is linked to colorectal carcinoma.